-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Pelthos Therapeutics Inc. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Dec 2022 to 31 Mar 2025.
- Pelthos Therapeutics Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $632,126, a 68% increase year-over-year.
- Pelthos Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $5,792,483, a 490% decline from 2023.
- Pelthos Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $981,031, a 37% increase from 2022.